If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
2
Followers on Owler
Adeptrix
is a biotechnology company that develops and commercializes BAMS assay kits for virology research and clinical diagnostics centers...
Read more
Overview
Competitors
Funding
News & Insights
Adeptrix
is a biotechnology company that develops and commercializes BAMS assay kits for virology research and clinical diagnostics centers...
Read more
Founder & CEO
Vladislav Bergo
CEO Approval Rating
90/100
Weigh In
2010
Beverly
Massachusetts
Greater Boston
Private
Pharmaceuticals & Biotechnology
Biotechnology
Life Sciences
http://adeptrix.com
Est. Annual Revenue
$100K-5.0M
Agree?
Yes
No
Est. Employees
25-100
Agree?
Yes
No
News
Latest News
Jan 06, 2021
Venture Capital Access Online
Adeptrix: Adeptrix Closes Series A Financing to Commercialize BAMS Bioanalytical Reagents for Life Science Research
Jul 28, 2020
Cambridge Independent
Adeptrix: Covid-19 test developed by Avacta and Adeptrix to be evaluated by government's CONDOR programme
Jul 22, 2020
Cambridge Network
Adeptrix: Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test
Jun 09, 2020
MarketScreener
Adeptrix: Avacta : Provides Update on COVID-19 Antigen Diagnostic Test Development With Adeptrix
May 14, 2020
Clinical Lab Products
Adeptrix: Avacta Group and Adeptrix Collaborating to Develop Covid-19 Antigen Test
May 01, 2020
360DX
Adeptrix: Avacta, Adeptrix Collaborate on Coronavirus Antigen Test
May 01, 2020
Business Weekly
Adeptrix: Avacta and US partner developing antigen test to fight COVID-19
Follow and Get Alerts
Adeptrix Competitors
1
Follow
2
Follow
3
Follow
Unlock more competitors
Trending Companies